Catalyst Wire Dossier Catalyst Wire Dossier

Gene therapy product for Pompe disease

· Astellas Gene Therapies
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gene therapy product for Pompe disease, covering 2026-02-02 to 2026-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Gene Transfer Study in Patients With Late Onset Pompe Disease [Phase 1, Phase 2]

See pricing